Senior VP, Clinical Development

Dr. Agro completed his Ph.D. from the Department of Medicine at McMaster University in 1995. After a short post-doctoral fellowship at the University of Florence in Italy, Dr. Agro accepted an academic position as assistant professor, Department of Pathology and Molecular Medicine at McMaster University in Hamilton, Ontario which he still maintains today. In early 1996 he joined Boehringer Ingelheim Canada Ltd as a Project Manager in drug development. In 1998, Dr. Agro joined Bayer Inc. as Director, Cardiopulmonary Research and shortly thereafter became responsible for the international development of Bayers lipid-lowering agent Baycol out of Wuppertal, Germany. Offered the position of Therapeutic Area Director, Immunology, Virology and Respiratory Medicine, Dr. Agro, re-joined Boehringer Ingelheim in late 2000. In 2003, Dr. Agro jointly formed the Clinical Research arm of Axon Medical Communications. This team became known as a virtual medical department without a pharmaceutical company attached. By offering all the services of any pharma/biotech in-house medical department, Axon CR partnered in drug development programs for big pharma and biotech alike. Dr. Agro has been working as a consultant to TransTech Pharma since 2003 and joined the firm full time in 2007.